News
In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...
Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
1h
Swisher Post on MSNCountries urged to urgently step up to transform their HIV responses amid global funding crisisGlobal Aids Update report titled, ’Aids, Crisis and the Power to Transform’, emphasises the urgent need for countries to ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care The Big Story Global HIV program a ...
Explore more
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
3h
VnExpress International on MSNThailand reports 13,000 new HIV cases this year, sharp rise among youth and tourist areasThailand has reported over 13,000 new HIV cases so far this year, with infections surging among young people as condom use ...
Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results